Abbott Labs Earnings, Revenue beat in Q4 By Investing.com

Abbott Labs (NYSE:ABT) reported on Wednesday fourth quarter earnings that beat analysts’ forecasts and revenue that topped expectations.

Abbott Labs announced earnings per share of $1.45 on revenue of $10.70B. Analysts polled by Investing.com anticipated EPS of $1.35 on revenue of $9.94B.

Abbott Labs shares are down 5% from the beginning of the year and are trading at $117.87 , down-from-52-week-high.They are under-performing the S&P 500 which is up 2.49% from the start of the year.

Abbott Labs shares gained 2.74% in pre-market trade the report.

Abbott Labs follows other major Healthcare sector earnings this month

Abbott Labs’s report follows an earnings beat by J&J on Tuesday, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.83 on revenue of $21.69B.

Novartis ADR had missed expectations on Tuesday with fourth quarter EPS of $1.34 on revenue of $12.77B, compared to forecast for EPS of $1.36 on revenue of $12.92B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar